Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer.
- Rolfo, Christian
- Manca, Paolo
- Salgado, Roberto
- Van Dam, Peter
- Dendooven, Amelie
- Machado Coelho, Andreia
- Ferri Gandia, Jose
- Rutten, Annemie
- Lybaert, Willem
- Vermeij, Joanna
- Gevaert, Thomas
- Weyn, Christine
- Lefebure, Anneke
- Metsu, Sofie
- Van Laere, Steven
- Peeters, Marc
- Pauwels, Patrick
Publication date
January 2018
DOI Publisher
BMJ ISSN
2059-7029 Citation count (estimate)
3Abstract
The complexity of delivering precision medicine to oncology patients has led to the creation of molecular tumourboards (MTBs) for patient selection and assessment of treatment options. New technologies like the liquid biopsy are augmenting available therapeutic opportunities. This report aims to analyse the experience of our MTB in the implementation of personalised medicine in a cancer network.info:eu-repo/semantics/publishe
Add to ORKG